SCNI
Price
$3.51
Change
-$0.06 (-1.68%)
Updated
Jan 17 closing price
Capitalization
2.99M
ZLDAF
Price
$0.35
Change
-$0.03 (-7.89%)
Updated
Jan 3 closing price
Capitalization
4.44M
Ad is loading...

SCNI vs ZLDAF

Header iconSCNI vs ZLDAF Comparison
Open Charts SCNI vs ZLDAFBanner chart's image
Scinai Immunotherapeutics
Price$3.51
Change-$0.06 (-1.68%)
Volume$4.85K
Capitalization2.99M
Zelira Therapeutics
Price$0.35
Change-$0.03 (-7.89%)
Volume$342
Capitalization4.44M
SCNI vs ZLDAF Comparison Chart
Loading...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCNI vs. ZLDAF commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCNI is a Hold and ZLDAF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (SCNI: $3.51 vs. ZLDAF: $0.35)
Brand notoriety: SCNI and ZLDAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SCNI: 46% vs. ZLDAF: 89%
Market capitalization -- SCNI: $2.99M vs. ZLDAF: $4.44M
SCNI [@Biotechnology] is valued at $2.99M. ZLDAF’s [@Biotechnology] market capitalization is $4.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCNI’s FA Score shows that 2 FA rating(s) are green whileZLDAF’s FA Score has 0 green FA rating(s).

  • SCNI’s FA Score: 2 green, 3 red.
  • ZLDAF’s FA Score: 0 green, 5 red.
According to our system of comparison, SCNI is a better buy in the long-term than ZLDAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCNI’s TA Score shows that 5 TA indicator(s) are bullish.

  • SCNI’s TA Score: 5 bullish, 4 bearish.

Price Growth

SCNI (@Biotechnology) experienced а -0.57% price change this week, while ZLDAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

SCNI is expected to report earnings on May 02, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLDAF($4.44M) has a higher market cap than SCNI($2.99M). SCNI YTD gains are higher at: 4.933 vs. ZLDAF (-7.389).
SCNIZLDAFSCNI / ZLDAF
Capitalization2.99M4.44M67%
EBITDA7.8MN/A-
Gain YTD4.933-7.389-67%
P/E Ratio1.46N/A-
Revenue452KN/A-
Total Cash1.03MN/A-
Total Debt1.23MN/A-
FUNDAMENTALS RATINGS
SCNI vs ZLDAF: Fundamental Ratings
SCNI
ZLDAF
OUTLOOK RATING
1..100
933
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8100
PRICE GROWTH RATING
1..100
6164
P/E GROWTH RATING
1..100
55100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCNI's Valuation (24) in the Pharmaceuticals Major industry is in the same range as ZLDAF (36) in the null industry. This means that SCNI’s stock grew similarly to ZLDAF’s over the last 12 months.

SCNI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ZLDAF (100) in the null industry. This means that SCNI’s stock grew similarly to ZLDAF’s over the last 12 months.

SCNI's SMR Rating (8) in the Pharmaceuticals Major industry is significantly better than the same rating for ZLDAF (100) in the null industry. This means that SCNI’s stock grew significantly faster than ZLDAF’s over the last 12 months.

SCNI's Price Growth Rating (61) in the Pharmaceuticals Major industry is in the same range as ZLDAF (64) in the null industry. This means that SCNI’s stock grew similarly to ZLDAF’s over the last 12 months.

SCNI's P/E Growth Rating (55) in the Pharmaceuticals Major industry is somewhat better than the same rating for ZLDAF (100) in the null industry. This means that SCNI’s stock grew somewhat faster than ZLDAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCNI
RSI
ODDS (%)
Bearish Trend 5 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with WINT. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-1.54%
WINT - SCNI
89%
Closely correlated
-3.44%
NBY - SCNI
88%
Closely correlated
+4.70%
NCNA - SCNI
88%
Closely correlated
+2.70%
SNPX - SCNI
88%
Closely correlated
N/A
RNAC - SCNI
86%
Closely correlated
+1.90%
More

ZLDAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDAF has been loosely correlated with BMEA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDAF jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDAF
1D Price
Change %
ZLDAF100%
N/A
BMEA - ZLDAF
37%
Loosely correlated
-2.09%
QLGN - ZLDAF
33%
Loosely correlated
+1.75%
SCNI - ZLDAF
32%
Poorly correlated
-1.54%
LYEL - ZLDAF
27%
Poorly correlated
+2.97%
YECO - ZLDAF
26%
Poorly correlated
N/A
More